BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27034887)

  • 1. Altered Mitochondrial Respiration and Other Features of Mitochondrial Function in Parkin-Mutant Fibroblasts from Parkinson's Disease Patients.
    Haylett W; Swart C; van der Westhuizen F; van Dyk H; van der Merwe L; van der Merwe C; Loos B; Carr J; Kinnear C; Bardien S
    Parkinsons Dis; 2016; 2016():1819209. PubMed ID: 27034887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial impairment observed in fibroblasts from South African Parkinson's disease patients with parkin mutations.
    van der Merwe C; Loos B; Swart C; Kinnear C; Henning F; van der Merwe L; Pillay K; Muller N; Zaharie D; Engelbrecht L; Carr J; Bardien S
    Biochem Biophys Res Commun; 2014 May; 447(2):334-40. PubMed ID: 24721425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts.
    Grünewald A; Voges L; Rakovic A; Kasten M; Vandebona H; Hemmelmann C; Lohmann K; Orolicki S; Ramirez A; Schapira AH; Pramstaller PP; Sue CM; Klein C
    PLoS One; 2010 Sep; 5(9):e12962. PubMed ID: 20885945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
    Koentjoro B; Park JS; Sue CM
    Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In search for mitochondrial biomarkers of Parkinson's disease: Findings in parkin-mutant human fibroblasts.
    Kamienieva I; Charzyńska A; Duszyński J; Malińska D; Szczepanowska J
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166787. PubMed ID: 37302428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Impact of
    Zilocchi M; Colugnat I; Lualdi M; Meduri M; Marini F; Corasolla Carregari V; Moutaoufik MT; Phanse S; Pieroni L; Babu M; Garavaglia B; Fasano M; Alberio T
    Front Cell Dev Biol; 2020; 8():423. PubMed ID: 32596240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulnerable Parkin Loss-of-Function
    Cackovic J; Gutierrez-Luke S; Call GB; Juba A; O'Brien S; Jun CH; Buhlman LM
    Front Cell Neurosci; 2018; 12():39. PubMed ID: 29497364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.
    Rakovic A; Grünewald A; Seibler P; Ramirez A; Kock N; Orolicki S; Lohmann K; Klein C
    Hum Mol Genet; 2010 Aug; 19(16):3124-37. PubMed ID: 20508036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
    Pinto M; Nissanka N; Moraes CT
    J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
    [No Abstract]   [Full Text] [Related]  

  • 11. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
    Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
    Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10.
    Bertolin G; Jacoupy M; Traver S; Ferrando-Miguel R; Saint Georges T; Grenier K; Ardila-Osorio H; Muriel MP; Takahashi H; Lees AJ; Gautier C; Guedin D; Coge F; Fon EA; Brice A; Corti O
    Cell Death Differ; 2015 Oct; 22(10):1563-76. PubMed ID: 25591737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.
    González-Casacuberta I; Morén C; Juárez-Flores DL; Esteve-Codina A; Sierra C; Catalán-García M; Guitart-Mampel M; Tobías E; Milisenda JC; Pont-Sunyer C; Martí MJ; Cardellach F; Tolosa E; Artuch R; Ezquerra M; Fernández-Santiago R; Garrabou G
    Neurobiol Aging; 2018 May; 65():206-216. PubMed ID: 29501959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction in Parkinson disease: evidence in mutant PARK2 fibroblasts.
    Zanellati MC; Monti V; Barzaghi C; Reale C; Nardocci N; Albanese A; Valente EM; Ghezzi D; Garavaglia B
    Front Genet; 2015; 6():78. PubMed ID: 25815004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid profiling of parkin-mutant human skin fibroblasts.
    Lobasso S; Tanzarella P; Vergara D; Maffia M; Cocco T; Corcelli A
    J Cell Physiol; 2017 Dec; 232(12):3540-3551. PubMed ID: 28109117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endoplasmic reticulum-mitochondria interface is perturbed in PARK2 knockout mice and patients with PARK2 mutations.
    Gautier CA; Erpapazoglou Z; Mouton-Liger F; Muriel MP; Cormier F; Bigou S; Duffaure S; Girard M; Foret B; Iannielli A; Broccoli V; Dalle C; Bohl D; Michel PP; Corvol JC; Brice A; Corti O
    Hum Mol Genet; 2016 Jul; 25(14):2972-2984. PubMed ID: 27206984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
    Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
    Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila.
    Zanon A; Kalvakuri S; Rakovic A; Foco L; Guida M; Schwienbacher C; Serafin A; Rudolph F; Trilck M; Grünewald A; Stanslowsky N; Wegner F; Giorgio V; Lavdas AA; Bodmer R; Pramstaller PP; Klein C; Hicks AA; Pichler I; Seibler P
    Hum Mol Genet; 2017 Jul; 26(13):2412-2425. PubMed ID: 28379402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease.
    Biswas S; Roy R; Biswas R; Bagchi A
    Gene; 2020 Feb; 726():144186. PubMed ID: 31647998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoskeletal Alterations and Biomechanical Properties of parkin-Mutant Human Primary Fibroblasts.
    Vergara D; Ferraro MM; Cascione M; del Mercato LL; Leporatti S; Ferretta A; Tanzarella P; Pacelli C; Santino A; Maffia M; Cocco T; Rinaldi R; Gaballo A
    Cell Biochem Biophys; 2015 Apr; 71(3):1395-404. PubMed ID: 25399302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.